An Active Pharmaceutical Ingredient (API) is the biologically active substance within a drug that exerts its core therapeutic efficacy; it serves as the fundamental cornerstone of pharmaceutical research, development, and manufacturing. As a specialized brand deeply rooted in the pharmaceutical sector, Cosper leverages China's comprehensive pharmaceutical industrial ecosystem to create a series of high-purity, high-stability API products—centering its operations on compliant manufacturing, meticulous quality control, and customized services.
As a trusted supplier, we focus on major therapeutic areas—including oncology, anti-infectives, and cardiovascular medicine. We strictly adhere to GMP guidelines and international pharmacopoeia standards, maintaining rigorous quality control throughout the entire process—from raw material selection to finished product release. By providing stable and reliable API solutions to pharmaceutical companies and research institutions worldwide, we facilitate the safe and efficient market launch of new medications.
1. The Core of Efficacy: APIs determine a drug's therapeutic effect, mechanism of action, and scope of application; they constitute the central target of pharmaceutical research and development.
2. The Cornerstone of Safety: An API's purity, impurity profile, and stability directly impact a drug's safety profile, necessitating strict compliance with rigorous regulatory standards.
3. The Core of the Industry: API manufacturing represents a critical link in the pharmaceutical supply chain, bridging the gap between chemical raw materials and finished drug formulations, thereby influencing the stability of the global pharmaceutical supply.
Cosper's API portfolio spans multiple therapeutic areas, with core categories including:
1. Anti-Infectives: Antibiotic APIs such as Amoxicillin, Cephalosporins, and Azithromycin.
2. Cardiovascular/Chronic Disease Management: APIs for chronic disease treatment, such as Metformin, Atorvastatin, and Amlodipine.
3. Oncology: APIs for targeted therapies, such as Imatinib and Sorafenib.
4. Antipyretics & Analgesics: Commonly used APIs such as Acetaminophen and Ibuprofen.
As a professional manufacturer, Cosper operates its own standardized manufacturing facilities. We strictly adhere to international standards—including China GMP, US USP, and European EP—and hold official certifications from regulatory bodies such as the FDA and EMA. Our entire production process is fully traceable, ensuring that our products consistently meet global regulatory requirements.
- Employing advanced synthesis processes and purification technologies, the product maintains a stable purity of ≥99.5%, with impurity levels kept below 0.1%;
- A comprehensive quality testing system has been established, equipped with precision instruments such as HPLC, GC, and MS to conduct full-scope testing on every product batch;
- Key parameters—including moisture content, residual solvents, and crystal form—are strictly controlled to ensure the product meets stability standards throughout its entire shelf life.
- We offer a one-stop service encompassing process R&D, pilot-scale amplification, and large-scale manufacturing; Active Pharmaceutical Ingredients (APIs) with specific specifications, crystal forms, or purity levels can be customized to meet client requirements;
- Production capacity is flexibly adjusted to ensure the reliable delivery of both small-batch custom orders and large-volume requests, thereby shortening lead times.
- A professional R&D team has been assembled to continuously optimize synthesis routes, enhance product yields, and reduce production costs;
- We adopt eco-friendly, "green" manufacturing processes to minimize the use of organic solvents and reduce waste emissions, aligning with the principles of sustainable development.
